Scott Armstrong is the Chairman of Pediatric Oncology at the Dana Farber Cancer Institute and Associate Chief of the Division of Hematology and Oncology at Boston Children’s Hospital. He was previously the Director of the Center for Epigenetics Research at Memorial Sloan Kettering Cancer Center and Professor of Pediatrics at the Weill Cornell Medical College where he initiated a research program in cancer epigenetics that has made significant contributions to the understanding of cancer biology. The major focus of his career has been on delineating the biology of childhood cancers, particularly leukemia. His work has led to the development of new therapeutic approaches for multiple types of cancer that are now being tested. Dr. Armstrong received his MD and PhD from the University of Texas Southwestern Medical School in Dallas, Texas. He performed his residency and fellowship in pediatric hematology/oncology at Children’s Hospital Boston, the Dana Farber Cancer Institute, and Harvard Medical School. Dr. Armstrong's work has been recognized by multiple awards including the Till and McCulloch Award from the International Society of Experimental Hematology, the Paul Marks Prize for Cancer Research from Memorial Sloan Kettering Cancer Center, the E. Mead Johnson Award from the Society for Pediatric Research, and the Dameshek Prize from the American Society of Hematology. He is an elected member of the American Society of Clinical Investigation (ASCI), the Association of American Physicians (AAP), and is a member of the U.S. National Academy of Medicine.